127 related articles for article (PubMed ID: 37803917)
1. Targeting Nanoplatform for Atherosclerosis Inhibition and Degradation via a Dual-Track Reverse Cholesterol Transport Strategy.
Chen Z; Zhu Q; Li D; Lv Q; Fu G; Ma B; Zhang W
Small; 2024 Feb; 20(7):e2306457. PubMed ID: 37803917
[TBL] [Abstract][Full Text] [Related]
2. Targeting Theranostics of Atherosclerosis by Dual-Responsive Nanoplatform via Photoacoustic Imaging and Three-In-One Integrated Lipid Management.
Ma B; Xiao Y; Lv Q; Li G; Wang Y; Fu G
Adv Mater; 2023 Feb; 35(5):e2206129. PubMed ID: 36394179
[TBL] [Abstract][Full Text] [Related]
3. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
4. Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression.
Guo Y; Yuan W; Yu B; Kuai R; Hu W; Morin EE; Garcia-Barrio MT; Zhang J; Moon JJ; Schwendeman A; Eugene Chen Y
EBioMedicine; 2018 Feb; 28():225-233. PubMed ID: 29361501
[TBL] [Abstract][Full Text] [Related]
5. A Novel Candidate for Prevention and Treatment of Atherosclerosis: Urolithin B Decreases Lipid Plaque Deposition in apoE
Zhao W; Wang L; Haller V; Ritsch A
Mol Nutr Food Res; 2019 May; 63(10):e1800887. PubMed ID: 30762936
[TBL] [Abstract][Full Text] [Related]
6. QiShenYiQi pill inhibits atherosclerosis by promoting reverse cholesterol transport PPARγ-LXRα/β-ABCA1 pathway.
Xie J; Peng L; Wang T; Yang C; Chen N; Feng X; Wu T; Xu T; Chen Y
J Ethnopharmacol; 2023 Oct; 315():116684. PubMed ID: 37230281
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.
Zimmer S; Grebe A; Bakke SS; Bode N; Halvorsen B; Ulas T; Skjelland M; De Nardo D; Labzin LI; Kerksiek A; Hempel C; Heneka MT; Hawxhurst V; Fitzgerald ML; Trebicka J; Björkhem I; Gustafsson JÅ; Westerterp M; Tall AR; Wright SD; Espevik T; Schultze JL; Nickenig G; Lütjohann D; Latz E
Sci Transl Med; 2016 Apr; 8(333):333ra50. PubMed ID: 27053774
[TBL] [Abstract][Full Text] [Related]
8. Anionic nanoliposomes reduced atherosclerosis progression in Low Density Lipoprotein Receptor (LDLR) deficient mice fed a high fat diet.
Krishna SM; Moxon JV; Jose RJ; Li J; Sahebkar A; Jaafari MR; Hatamipour M; Liu D; Golledge J
J Cell Physiol; 2018 Oct; 233(10):6951-6964. PubMed ID: 29741759
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine accelerates atherosclerosis via inhibiting LXRα-mediated ABCA1/ABCG1-dependent cholesterol efflux from macrophages.
Jin P; Bian Y; Wang K; Cong G; Yan R; Sha Y; Ma X; Zhou J; Yuan Z; Jia S
Life Sci; 2018 Dec; 214():41-50. PubMed ID: 30393020
[TBL] [Abstract][Full Text] [Related]
10. Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation.
Luo Y; Guo Y; Wang H; Yu M; Hong K; Li D; Li R; Wen B; Hu D; Chang L; Zhang J; Yang B; Sun D; Schwendeman AS; Eugene Chen Y
EBioMedicine; 2021 Dec; 74():103725. PubMed ID: 34879325
[TBL] [Abstract][Full Text] [Related]
11. Lactobacillus acidophilus K301 Inhibits Atherogenesis via Induction of 24 (S), 25-Epoxycholesterol-Mediated ABCA1 and ABCG1 Production and Cholesterol Efflux in Macrophages.
Hong YF; Kim H; Kim HS; Park WJ; Kim JY; Chung DK
PLoS One; 2016; 11(4):e0154302. PubMed ID: 27120199
[TBL] [Abstract][Full Text] [Related]
12. QiShenYiQi pill inhibits atherosclerosis by promoting TTC39B-LXR mediated reverse cholesterol transport in liver.
Wang TT; Yang CY; Peng L; Li L; Chen NT; Feng X; Xie J; Wu TC; Xu T; Chen YZ
Phytomedicine; 2024 Jan; 123():155192. PubMed ID: 37951148
[TBL] [Abstract][Full Text] [Related]
13. Synthetic high-density lipoproteins delivering liver X receptor agonist prevent atherogenesis by enhancing reverse cholesterol transport.
Yuan W; Yu B; Yu M; Kuai R; Morin EE; Wang H; Hu D; Zhang J; Moon JJ; Chen YE; Guo Y; Schwendeman A
J Control Release; 2021 Jan; 329():361-371. PubMed ID: 33188828
[TBL] [Abstract][Full Text] [Related]
14. Epsin Nanotherapy Regulates Cholesterol Transport to Fortify Atheroma Regression.
Cui K; Gao X; Wang B; Wu H; Arulsamy K; Dong Y; Xiao Y; Jiang X; Malovichko MV; Li K; Peng Q; Lu YW; Zhu B; Zheng R; Wong S; Cowan DB; Linton M; Srivastava S; Shi J; Chen K; Chen H
Circ Res; 2023 Jan; 132(1):e22-e42. PubMed ID: 36444722
[TBL] [Abstract][Full Text] [Related]
15. IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages.
Gabunia K; Ellison S; Kelemen S; Kako F; Cornwell WD; Rogers TJ; Datta PK; Ouimet M; Moore KJ; Autieri MV
Am J Pathol; 2016 May; 186(5):1361-74. PubMed ID: 26952642
[TBL] [Abstract][Full Text] [Related]
16. Brothers in Arms: ABCA1- and ABCG1-Mediated Cholesterol Efflux as Promising Targets in Cardiovascular Disease Treatment.
Frambach SJCM; de Haas R; Smeitink JAM; Rongen GA; Russel FGM; Schirris TJJ
Pharmacol Rev; 2020 Jan; 72(1):152-190. PubMed ID: 31831519
[TBL] [Abstract][Full Text] [Related]
17. The combination of L-4F and simvastatin stimulate cholesterol efflux and related proteins expressions to reduce atherosclerotic lesions in apoE knockout mice.
Ying R; Yuan Y; Qin YF; Tian D; Feng L; Guo ZG; Sun YX; Li MX
Lipids Health Dis; 2013 Dec; 12():180. PubMed ID: 24314261
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
19. Andrographolide Inhibits Oxidized LDL-Induced Cholesterol Accumulation and Foam Cell Formation in Macrophages.
Lin HC; Lii CK; Chen HC; Lin AH; Yang YC; Chen HW
Am J Chin Med; 2018; 46(1):87-106. PubMed ID: 29298513
[TBL] [Abstract][Full Text] [Related]
20. Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability.
Nidorf SM; Fiolet A; Abela GS
J Clin Lipidol; 2020; 14(5):619-630. PubMed ID: 32792218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
